L Daniel Browne Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for L Daniel Browne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of L Daniel Browne. L Daniel Browne is CEO and President in Revance Therapeutics, Inc. ($RVNC).
Latest Insider Trading Transactions of L Daniel Browne
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | J | 11.02 | 1,000 | 11,025 | 152,193 | 151.2 K to 152.2 K (+0.66 %) |
Mar 19 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 15.51 | 11,613 | 180,068 | 151,193 | 162.8 K to 151.2 K (-7.13 %) |
Mar 19 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 15.45 | 2,881 | 44,511 | 162,806 | 165.7 K to 162.8 K (-1.74 %) |
Mar 19 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 15.45 | 3,256 | 50,305 | 165,687 | 168.9 K to 165.7 K (-1.93 %) |
Feb 20 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 17.68 | 5,446 | 96,285 | 168,943 | 174.4 K to 168.9 K (-3.12 %) |
Feb 20 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 17.68 | 5,446 | 96,285 | 168,943 | 174.4 K to 168.9 K (-3.12 %) |
Feb 20 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 17.69 | 3,154 | 55,794 | 174,389 | 177.5 K to 174.4 K (-1.78 %) |
Feb 20 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 17.69 | 3,154 | 55,794 | 174,389 | 177.5 K to 174.4 K (-1.78 %) |
Jan 25 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 17.23 | 200,000 | 3,446,000 | 200,000 | |
Jan 25 2019 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Grant | A | 0.00 | 35,000 | 0 | 177,543 | 142.5 K to 177.5 K (+24.55 %) |
Jul 03 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | J | 23.33 | 668 | 15,586 | 142,543 | 141.9 K to 142.5 K (+0.47 %) |
Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | M | 2.55 | 20,000 | 51,000 | 0 | |
Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 31.43 | 5,452 | 171,348 | 141,875 | 147.3 K to 141.9 K (-3.70 %) |
Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | M | 2.55 | 20,000 | 51,000 | 147,327 | 127.3 K to 147.3 K (+15.71 %) |
Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 31.65 | 2,881 | 91,184 | 127,327 | 130.2 K to 127.3 K (-2.21 %) |
Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 32.80 | 1,000 | 32,800 | 130,208 | 131.2 K to 130.2 K (-0.76 %) |
Mar 09 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 31.43 | 27,283 | 857,505 | 131,208 | 158.5 K to 131.2 K (-17.21 %) |
Feb 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 31.75 | 3,074 | 97,600 | 158,491 | 161.6 K to 158.5 K (-1.90 %) |
Feb 09 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 29.15 | 169,000 | 4,926,350 | 169,000 | |
Feb 09 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Grant | A | 0.00 | 28,250 | 0 | 161,565 | 133.3 K to 161.6 K (+21.19 %) |
Jan 03 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | J | 22.99 | 127 | 2,920 | 133,315 | 133.2 K to 133.3 K (+0.10 %) |
Nov 24 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 24.94 | 7,600 | 189,570 | 133,188 | 140.8 K to 133.2 K (-5.40 %) |
Oct 20 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 26.16 | 7,662 | 200,405 | 140,788 | 148.5 K to 140.8 K (-5.16 %) |
Sep 22 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 23.58 | 7,600 | 179,185 | 148,450 | 156.1 K to 148.5 K (-4.87 %) |
Aug 25 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | M | 2.55 | 331 | 844 | 10,990 | |
Aug 25 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 22.76 | 22,800 | 519,031 | 156,050 | 178.9 K to 156.1 K (-12.75 %) |
Aug 25 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | M | 2.55 | 331 | 844 | 178,850 | 178.5 K to 178.9 K (+0.19 %) |
Jul 05 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | J | 18.32 | 1,000 | 18,318 | 178,519 | 177.5 K to 178.5 K (+0.56 %) |
Jun 14 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | M | 2.55 | 8,300 | 21,165 | 11,321 | |
Jun 14 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | M | 2.55 | 8,300 | 21,165 | 177,519 | 169.2 K to 177.5 K (+4.90 %) |
May 31 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | M | 2.55 | 5,000 | 12,750 | 19,621 | |
May 31 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | M | 2.55 | 5,000 | 12,750 | 169,219 | 164.2 K to 169.2 K (+3.04 %) |
May 24 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 20.35 | 19,713 | 401,091 | 164,219 | 183.9 K to 164.2 K (-10.72 %) |
May 24 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 20.20 | 12,287 | 248,159 | 183,932 | 196.2 K to 183.9 K (-6.26 %) |
Mar 17 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 19.20 | 3,171 | 60,885 | 196,219 | 199.4 K to 196.2 K (-1.59 %) |
Feb 24 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 20.70 | 1,269 | 26,263 | 199,390 | 200.7 K to 199.4 K (-0.63 %) |
Feb 24 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 20.56 | 9,768 | 200,787 | 200,659 | 210.4 K to 200.7 K (-4.64 %) |
Jan 30 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 19.70 | 155,000 | 3,053,500 | 155,000 | |
Jan 30 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Grant | A | 0.00 | 25,800 | 0 | 210,427 | 184.6 K to 210.4 K (+13.97 %) |
Jan 27 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 19.78 | 12,000 | 237,398 | 184,627 | 196.6 K to 184.6 K (-6.10 %) |
Jan 03 2017 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | J | 11.58 | 1,000 | 11,577 | 196,627 | 195.6 K to 196.6 K (+0.51 %) |
Dec 30 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 20.94 | 12,000 | 251,250 | 195,627 | 207.6 K to 195.6 K (-5.78 %) |
Nov 25 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 18.70 | 822 | 15,371 | 207,627 | 208.4 K to 207.6 K (-0.39 %) |
Nov 25 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 17.86 | 11,178 | 199,633 | 208,449 | 219.6 K to 208.4 K (-5.09 %) |
Oct 28 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 14.85 | 12,000 | 178,199 | 219,627 | 231.6 K to 219.6 K (-5.18 %) |
May 23 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 17.11 | 12,050 | 206,176 | 231,627 | 243.7 K to 231.6 K (-4.95 %) |
Feb 11 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 17.12 | 175,000 | 2,996,000 | 175,000 | |
Feb 11 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Grant | A | 0.00 | 25,000 | 0 | 243,677 | 218.7 K to 243.7 K (+11.43 %) |
Jan 04 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | M | 2.55 | 12,045 | 30,715 | 24,621 | |
Jan 04 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | J | 27.00 | 262 | 7,074 | 218,677 | 218.4 K to 218.7 K (+0.12 %) |
Jan 04 2016 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | M | 2.55 | 12,045 | 30,715 | 218,415 | 206.4 K to 218.4 K (+5.84 %) |
Jul 02 2015 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | J | 14.16 | 1,000 | 14,160 | 1,000 | 0 to 1,000 |
May 21 2015 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 25.94 | 12,025 | 311,929 | 205,101 | 217.1 K to 205.1 K (-5.54 %) |
Jan 30 2015 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 16.23 | 246,500 | 4,000,695 | 246,500 | |
Jan 30 2015 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Grant | A | 0.00 | 43,500 | 0 | 217,126 | 173.6 K to 217.1 K (+25.05 %) |
Dec 01 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | P | 16.67 | 6,000 | 100,019 | 172,626 | 166.6 K to 172.6 K (+3.60 %) |
May 21 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 32.22 | 295,800 | 9,530,676 | 295,800 | |
May 21 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Grant | A | 32.22 | 96,000 | 3,093,120 | 166,626 | 70.6 K to 166.6 K (+135.93 %) |
Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | A | 9.15 | 99,583 | 911,184 | 99,583 | |
Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | C | 0.00 | 409 | 0 | 0 | |
Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | C | 0.00 | 17,293 | 0 | 0 | |
Feb 11 2014 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | C | 0.00 | 17,702 | 0 | 71,035 | 53.3 K to 71 K (+33.19 %) |
Page: 1